PNA Center for Neurological Research

The PNA Center for Neurological Research (PCNR) is a biotechnology research organization focused on developing novel therapeutic interventions for severe neurological disorders using Peptide Nucleic Acid (PNA) technology. The center leverages the unique properties of PNAs—synthetic DNA mimics with a pseudopeptide backbone—to create highly stable and specific antisense agents capable of modulating gene expression. Their primary research programs target the underlying genetic causes of Huntington's Disease and Friedreich's Ataxia. By optimizing PNA delivery and binding affinity, PCNR aims to provide disease-modifying treatments for conditions that currently have limited therapeutic options. The organization operates at the intersection of academic innovation and translational drug development.